Initiator Pharma A/S: Financial statements 2023
CVR: 37663808
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Initiator Pharma A/S (CVR 37663808) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -23,413,000 and a net result of DKK -22,873,000 compared with DKK -38,455,000 the year before. Equity in the 2023 report amounted to DKK 11,162,000. The solvency ratio was 37.5%. The company had 2 employees in the financial year.
- Gross Profit
- DKK -23,413,000
- Profit/Loss
- DKK -22,873,000
- Equity
- DKK 11,162,000
- Total Assets
- DKK 29,786,000
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -23.4M | -22.9M | 11.2M | 2 |
| 2022 | - | -38.4M | -38.5M | 34M | 3 |
| 2021 | - | -22K | -21K | 35K | - |
| 2020 | - | -9.3M | -8.7M | 14.4M | 1 |
| 2019 | - | -8.4M | -8.3M | 9.9M | 1 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Initiator Pharma A/S has published its annual report for 2022. Gross profit came to DKK -38,425,000, and the net result was DKK -38,455,000.
About Initiator Pharma A/S
Initiator Pharma A/S is a Danish company of the type Aktieselskab based in København N, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Claus Elsborg Olesen. The board consists of Gunnar Magnus Severus Modée Persson (chair), Annette Ingegerd Marie Colin, Claus Elsborg Olesen and Majken Christina Östberg Lloyd. The company is owned by Linc AB and Adrigo Asset Management. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK -14,828,000 and a net result of DKK -13,687,000 compared with DKK -12,932,000 the year before. Equity in the 2025 report amounted to DKK 29,546,000.
